[smartslider3 slider=”3″]
We Pride Ourselves On Unwavering Excellence And Steadfast
Improvement Through The Years.
About Us
Based in Sugar Land, Texas, Kavis Pharma specializes in pharmaceutical manufacturing under Extrovis, our parent Company. Our plant features a rich legacy that dates back to 1976, and features nearly 50 years of experience in the manufacture of semi-solid and liquid products, while maintaining a stellar compliance history. Leveraging our vast industry experience, Kavis Pharma connects the dots between drug development and commercialization. Everything we do and every investment we make is grounded in our passion for delivering safe, predictable, and efficient results for our products and our partners.
Sound Business Structure
In tandem, Extrovis R&D structure and the Kavis commercial scale-up experience promote a robust platform for introducing new products to market, while also providing product lifecycle oversight. Factoring in Kavis’ proven Quality and Safety programs, the business is prepared to grow and adapt with the industry.
Talent Engagement & Retention
Kavis believes in leveraging effective communication, fostering growth opportunities, and providing superb benefits to attract and retain high caliber talent.
Flawless Execution
Kavis adopts a proactive approach in understanding all areas impacted by the business transition, and executing plans effectively.
How We Do It
For nearly a half century, our team has specialized in manufacturing non-sterile pharmaceutical compounds, including semi-solid and liquid pharmaceutical products in various forms. Moreover, our ability to produce highly potent compounds (including cytotoxics and hormones) with robust engineering controls sets us apart from most traditional non-sterile manufacturers.
Quality Assurance
Our dedication to quality assurance ensures a high level of reliability. We continuously enhance our quality management system to deliver high-quality products that meet customer demand. Through the implementation of advanced testing, analysis devices and the establishment of effective control systems, our facility ensures strict quality control and state-of-the-art products. We have established reliable quality control measures for raw materials, intermediate products, and finished goods, enabling rigorous quality evaluation.
Our Technologies
For nearly a half century, our team has specialized in manufacturing non-sterile pharmaceutical compounds, including semi-solid and liquid pharmaceutical products in various forms. Moreover, our ability to produce highly potent compounds (including cytotoxics and hormones) with robust engineering controls sets us apart from most traditional non-sterile manufacturers.
Product Capabilities
At Kavis, we develop products that cater to topical and oral routes of administration, with specialized capabilities that include hormones, cytotoxins, and high alcohol compounds.
Packing Capabilities
The value of our high quality packaging capabilities enhances the efficacy and lifespan of our products, and in the interim offers more cost-effective solutions.
Metal Tubes
Laminate Tubes
Jars
Bottles
Vials
Bulk Compounding Capabilities
Creams
Lotions
Gels
Ointments
Solutions
Suspensions
Service Capabilities
Our comprehensive range of services are designed to cater to your different requirements with utmost efficiency and expertise.
Analytical Method Validation
Clinical Trial Material Manufacturing
Stability Studies
Process Validation
Serialisation (DSCSA)
Program & Project Management
Suspensions
Our Team
Our legacy is our passion. Our discoveries and pharma products have helped make meaningful differences to healthcare and people’s lives.
Our team helps inform our purpose and progress.
Dr. Janos Vaczi
Managing Director – Extrovis
Janos brings with him a well-rounded set of skills in medical, sales, business development, finance, and administration which combined are instrumental for Extrovis’ commercial and partnership strategy and support the definition of the company’s portfolio and execution of the development projects. Before joining Extrovis in Switzerland he held various general management and P&L responsibilities at Amneal based in Switzerland, Alliance Healthcare (now part of Walgreens Boots Alliance), Ratiopharm (now part of the Teva Group), and Sanofi. Janos has a Summa Cum Laude degree from Szent-Györgyi Albert Medical University in Szeged, Hungary.
Danny Cracchiolo
General Manager
Danny Cracchiolo serves as General Manager of Kavis Pharma’s flagship manufacturing facility in Sugar Land, Texas. With 25 years of experience in the pharmaceutical sector, he oversees all operational aspects of the facility, including regulatory compliance, manufacturing, and financial performance. Danny has deep expertise in FDA, OSHA, and EPA compliance, lean manufacturing, change management, and continuous improvement methodologies.
He is committed to driving operational excellence by cultivating a culture of accountability and optimizing processes. Through his leadership, Danny fosters high-performing teams that consistently deliver innovative, complex products to customers while ensuring client satisfaction.